← Back to Search

Peer Navigators Addressing INtersectional Stigma to Improve HIV Prevention Among Criminal-Justice Involved Women for Human Immunodeficiency Virus Infection (kINSHIP Trial)

N/A

Waitlist Available

Led By Emily Dauria, PhD, MPH

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months post enrollment

Awards & highlights

kINSHIP Trial Summary

This trial will develop and test a peer-led patient navigation intervention to help women at risk of HIV acquisition who are involved in the criminal justice system. The intervention will aim to reduce stigma and improve uptake and linkage to pre-exposure prophylaxis (PrEP) services, thereby increasing access to PrEP and decreasing PrEP-related disparities.

Eligible Conditions

Human Immunodeficiency Virus (HIV) Infection
Social Stigma

kINSHIP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months post enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months post enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months post enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Linkage to PrEP services

Secondary outcome measures

Accepted PrEP prescription

Accepted PrEP referral

PrEP adherence

+3 more

kINSHIP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Active-kINSHIP navigation interventionExperimental Treatment1 Intervention

kINSHIP is a peer-led navigator intervention to address intersectional stigma and improve PrEP treatment initiation and engagement for justice-involved women. The key components of the kINSHIP intervention are to: 1) increase social support; 2) increase self-efficacy in accessing PrEP services; 3) enhance access to healthcare services; 4) improve adaptive coping skills to manage experiences of intersectional stigma.

Group II: Control-Standard CareActive Control1 Intervention

The control arm will be standard-of-care, which is as-needed case management for justice-involved women.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,465 Previous Clinical Trials

2,618,558 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,501 Previous Clinical Trials

15,236,496 Total Patients Enrolled

Emily Dauria, PhD, MPHPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial include participants aged 65 and over?

"The stated qualifications for this trial mandate that all participants must be between 18 and 49 years old."

Answered by AI

Who is the target demographic for this clinical experiment?

"Eligibility requirements for this medical trial include HIV infection and an age between 18 to 49. Up to 75 people are needed as participants."

Answered by AI

Are there still opportunities to join the study cohort?

"In accordance with the data on clinicaltrials.gov, this research is still recruiting participants. The trial was first published online in February of 2022 and has since been refreshed once more during that same month."

Answered by AI

How many people are receiving treatment in this experiment?

"Affirmative. According to the clinical trial information posted on clinicaltrials.gov, this medical investigation is presently looking for participants and was first published on February 20th 2022 with a last update occurring on February 1st of that same year. 75 individuals are needed from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIV Prevention Peer Navigation for Justice Involved Women

2022. "HIV Prevention Peer Navigation for Justice Involved Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04680390.